Belite Bio Inc - Adr (BLTE) 13F Holders & Ownership Data (82 Funds, Q2 2026)

BLTE ranks #5040 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

BLTE is a disclosed holding of Israel Englander (Millennium Management), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

BLTE is a top-conviction position for Darwin Global Management, Ltd. — at 12.1% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

Morgan Stanley has added to its BLTE position for two straight quarters, increasing it by $31.7M to reach $36.2M today.

Fred Alger Management, LLC has trimmed its BLTE position for two straight quarters, cutting it by $12.4M while still holding $326.3K.

BLTE is up 2.5% today, and institutions have been net buyers of $101.2M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

BLTE reported a net loss of $77.6M in its latest fiscal year.

• Not yet profitable — net loss of $77.6M in the latest fiscal year
• Net income declined year over year, from -$36.1M to -$77.6M
• Operating cash flow was negative, using $37.0M in cash
• Current ratio of 50.02x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.01x equity — within a conventional range